1 / 1

Braf mutation testing

NuProbe develops ultra-sensitive and highly multiplexed assays for non-invasive cancer profiling on NGS and qPCR / Sanger. NuProbe takes a multi-platform approach to use its breakthrough technologies in genomics allow diseases to be detected, treated, and cured at early stages for better outcomes with lower costs.

nuprobepancancer
Download Presentation

Braf mutation testing

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Customized qPCR/Sanger Assays and Services FEATURES SAMPLE DATA CUSTOMIZABLE Automatically design custom BDA assays RAPID TURNAROUND 2-3 days ULTRASENSITIVE Limit of detection down to 0.1% VAF Ultrasensitive custom sequencing panels Ultrasensitive custom sequencing panels to integrate the latest clinical genomics findings to integrate the latest clinical genomics findings VarMap™: NGS FEATURES SAMPLE DATA AFFORDABLE Only 1 million reads for liquid biopsy ULTRASENSITIVE Limit of detection down to 0.1% VAF QUANTITATIVE >95% VAF quantitation accuracy SAMPLE FLEXIBILITY Compatible with several sample types USA 2575 West Bellfort Avenue, Ste. 200 Houston, TX 77054 Email : customerservice@nuprobe.com Cell : +1 713-485-0148 Website : https://www.nuprobe.com/ CHINA 489 Zhengli Rd, Yangpu District Shanghai, China

More Related